May 5, 2026
Ajanta Pharma Q4 Revenue Jumps to ₹1,422 crore
Ajanta Pharma Limited — Quarter ended 31 March 2026 (FY ended 31 March 2026) Milestone Value Revenue crosses 5,000 cr. PAT crosses 1,000 cr. EBITDA close...
Latest posts
May 5, 2026
Ajanta Pharma Limited — Quarter ended 31 March 2026 (FY ended 31 March 2026) Milestone Value Revenue crosses 5,000 cr. PAT crosses 1,000 cr. EBITDA close...
May 5, 2026
DCW LIMITED — Quarter and year ended 31st March, 2026 Sr. No. Particulars M/s. PKF Sridhar & Santhanam LLP (Internal Auditors) M/s. R. Nanabhoy and Co....
May 5, 2026
Rallis India Limited — Q4 & FY26 Earnings Call (held Apr 28, 2026) 1. Overall Tone of Management: Neutral Management acknowledges material near-term headwinds: “near-term cost...
May 5, 2026
Kisan Mouldings Ltd. — Quarter and year ended March 31, 2026 Particulars Quarter ended March 31, 2026 (Audited) (Refer note 3) Quarter ended December 31, 2025...
May 5, 2026
Sayaji Industries Limited — Quarter and year ended March 31, 2026 Particulars Quarter ended Year ended March 31, 2026 (Audited) Dec 31, 2025 (Unaudited) March 31,...
May 5, 2026
Jindal Saw Limited — Q4 FY26 Earnings Call (Apr 28, 2026) 1. Overall Tone of Management: Neutral to Pessimistic Management acknowledges sharp declines in Q4/FY26 profitability...
May 5, 2026
Emcure Pharmaceuticals Limited — Quarter and year ended March 31, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Bandra Kurla...
May 5, 2026
Onward Technologies Limited — Quarter ended March 31, 2026 (and year ended March 31, 2026) Sr. No. Particulars Quarter ended March 31, 2026 Refer note 4...
May 5, 2026
LLOYDS ENGINEERING WORKS LIMITED — Quarter and year ended 31 March 2026 (Audited) The following tables are extracted from the provided document. Sr. No. Particulars Quarter...
May 5, 2026
Dolphin Offshore Enterprises (India) Limited — Quarter ended March 31, 2026 (Audited) and year ended March 31, 2026 (Audited) Sr. No. Particulars Quarter ended 31-03-2026 (Audited)...